Figures & data
Table 1. The primers for RT-qPCR
Figure 1. Ube2b expression was decreased in CCI rats
![Figure 1. Ube2b expression was decreased in CCI rats](/cms/asset/0a18cdaa-3abb-4a94-9ee9-2b0d2ae15a13/kbie_a_1976895_f0001_oc.jpg)
Figure 2. Ube2b elevation alleviated the mechanical hyperalgesia and thermal hyperalgesia in rats
![Figure 2. Ube2b elevation alleviated the mechanical hyperalgesia and thermal hyperalgesia in rats](/cms/asset/c38900f7-846a-46ae-80b0-631f796b6128/kbie_a_1976895_f0002_oc.jpg)
Figure 3. Ube2b elevation suppressed chronic sciatic nerve injury
![Figure 3. Ube2b elevation suppressed chronic sciatic nerve injury](/cms/asset/0067f05d-a2b9-474a-b9d0-3818a486152b/kbie_a_1976895_f0003_oc.jpg)
Figure 4. Ube2b regulated the expression of DNMT3a and Kcna2
![Figure 4. Ube2b regulated the expression of DNMT3a and Kcna2](/cms/asset/eb060fe8-9b20-4639-ac16-967c80e94f2e/kbie_a_1976895_f0004_oc.jpg)
Figure 5. Ube2b promoted the level of Kcna2 via regulating DNMT3a
![Figure 5. Ube2b promoted the level of Kcna2 via regulating DNMT3a](/cms/asset/067dea18-6635-4ff0-9ad6-89ce397b396a/kbie_a_1976895_f0005_oc.jpg)
Figure 6. Ube2b modulates neuropathic pain via mediating Kcna2
![Figure 6. Ube2b modulates neuropathic pain via mediating Kcna2](/cms/asset/15d07802-154f-44fa-894c-3f0cd2ad7c13/kbie_a_1976895_f0006_oc.jpg)